Clinical Trials Logo

Clinical Trial Summary

Tolerability is compared between two Multi-purpose disinfecting solutions (MPDS).


Clinical Trial Description

According to recent surveys of contact lens fitters, the most prescribed treatments for contact lens dryness are: more frequent replacement schedule (24%), refit into different material (23%), rewetting drops (21%) and change care system (15%). Changing care systems has been a standard treatment for CL discomfort for many years. In the same survey, 30% of practitioners felt there is absolutely no difference among solutions with respect to reducing dryness and discomfort.

The investigators set out to compare the clinical performance of these two solutions: AMO's RevitaLens and Alcon's Opti-Free PureMoist. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT01847105
Study type Interventional
Source Hom, Milton M., OD, FAAO
Contact
Status Enrolling by invitation
Phase N/A
Start date June 2013
Completion date May 2014

See also
  Status Clinical Trial Phase
Completed NCT00829751 - The Physiological Consequence of Silicone-hydrogel Care-solution Bio-incompatibility N/A
Completed NCT03193255 - Efficacy and Safety of cleadewGP for Rigid Contact Lenses N/A